IN8BIO, INC. — Director's Dealing 2022

Oct 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2022-10-21

Reporting Person: Goswami Trishna (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-21	Employee Stock Option (right to buy)	$1.48	A	68427	Acquired	2032-10-21	Common Stock (68427)	Direct

Footnotes

F1: The option will vest in three equal annual installments commencing on October 21, 2024, subject to the Reporting Person continuing to provide service through each such date.